Racial disparities in survival among patients with germ cell tumors of the ovary-United States

Gynecologic Oncology

Volumn 114, Issue 3, 2009, Pages 437-441

  Bryant, Christopher S ^a,b   Kumar, Sanjeev ^a,b   Shah, Jay P ^a,b   Mahdi, Haider ^a,b   Ali Fehmi, Rouba ^a,b   Munkarah, Adnan R ^a,c   Deppe, Gunter ^a,b   Morris, Robert T ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Germ cell tumor; Ovary; Racial disparity; Survival

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT TERATOMA; MIXED TUMOR; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; STATISTICAL ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 67651163409     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.039     Document Type: Article

References (32)

1. National Institutes of Health. The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. In. Washington, DC: National Cancer Institute U.S. Department of Health and Human Services; 2006.
2. U.S. Department of Health and Human Services. Healthy People 2010: understanding and improving health. In. Washington, DC: U.S. Department of Health and Human Services; 2000.
3. Maxwell G.L. Racial disparities research: it's not just black and white. Gynecol. Oncol. 101 (2006) 194-197
4. Allard J.E., and Maxwell G.L. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 16 (2009) 53-56
5. Chan J.K., Zhang M., Hu J.M., Shin J.Y., Osann K., and Kapp D.S. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in the United States. J. Surg. Oncol. 97 (2008) 103-107
6. Downs L.S., Smith J.S., Scarinci I., Flowers L., and Parham G. The disparity of cervical cancer in diverse populations. Gynecol. Oncol. 109 (2008) S22-S30
7. Steinberg M.L. Inequity in cancer care: explanations and solutions for disparity. Semin. Radiat. Oncol. 18 (2008) 161-167
8. Yood M.U., Johnson C.C., Blount A., Abrams J., Wolman E., McCarthy B.D., et al. Race and differences in breast cancer survival in a managed care population. J. Nat. Cancer Inst. 91 (1999) 1487-1491
9. Robbins A.S., Whittemore A.S., and Van Den Eeden S.K. Race, prostate cancer survival, and membership in a large health maintenance organization. J. Nat. Cancer Inst. 90 (1998) 986-990
10. Kumar S., Shah J.P., Bryant C.S., Imudia A.N., Cote M.L., Ali-fehmi R., et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol. Oncol. 110 (2008) 125-132
11. Gershenson D.M. Management of ovarian germ cell tumors. J. Clin. Oncol. 25 (2007) 2938-2943
12. McGuire V., Herrington L., and Whittemore A.S. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology 13 (2002) 231-234
13. Tammemaqi C.M. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr. Opin. Obstet. Gynecol. 19 (2007) 31-36
14. Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER* State Database: Incidence - SEER 17 Regs Limited Use. Nov 2006 Sub (1973-2004 varying) - Linked to County Attributes - Total U.S., 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. In.
15. Smith H.O., Berwick M., Verschraegen C.F., Wiggins C., Lansing L., Muller C.Y., et al. Incidence and survival rates for female malignant germ cell tumors. Obstet. Gynecol. 107 (2006) 1075-1085
16. Morice P., Joulie F., Camatte S., Atallah D., Rouzier R., Pautier P., et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J. Am. Coll. Surg. 197 (2003) 198-205
17. Ries L, Fritz A. SEER Extent of disease - 1988. Third editioned. National Cancer Institute; 1998. NIH. In.
18. Seiffert JE. SEER Program: comparative staging guide for cancer version 1.1: National Cancer Institute; 1988. NIH. In.
19. Creasman W.J. Announcement, FIGO stages 1988, revisions. Gynecol. Oncol. 31 (1989) 125-127
20. Lai C.H., Chang T.C., Hsueh S., Wu T.I., Chao A., Chou H.H., et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol. Oncol. 96 (2005) 784
21. Shah J.P., Kumar S., Bryant C.S., Ali-Fehmi R., Malone Jr. J.M., Deppe G., et al. population-based analysis of 788 cases of yolk sac tumors: a comparison of males and females. Int. J. Cancer 123 (2008) 2671-2675
22. McGuire V., Jesser C.A., and Whittemore A.S. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol. Oncol. 84 (2002) 399-403
23. Virnig B.A., Baxter N.N., Habermann E.B., Feldman R.D., and Bradley C.J. A matter of race: early-versus late-stage cancer diagnosis. Health Aff. (Millwood) 28 (2009) 160-168
24. Soliman P.T., Bassett Jr. R.L., Wilson E.B., Boyd-Rogers S., Schmeler K.M., Milam M.R., et al. Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet. Gynecol. 112 (2008) 835-842
25. Claldwell J., Hart-Johnson T., and Green C.R. Body mass index and quality of life: examining blacks and whites with chronic pain. J. Pain 10 (2009) 60-67
26. Parham G., Phillips J.L., Hicks M.L., Andrews N., Jones W.B., Shingleton H.M., et al. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 80 (1997) 816-826
27. Harlan L.C., Clegg L.X., and Trimble E.L. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J. Clin. Oncol. 21 (2003) 3488-3494
28. Farley J., Risinger J.I., Rose G.S., and Maxwell G.L. Racial disparities in blacks with gynecologic cancers. Cancer 110 (2007) 234-243
29. Harper S., Lynch J., Meersman S.C., Breen N., Davis W.W., and Reichman M.C. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women Ages 50 years and over (1987-2005). Cancer Epidemiol. Biomarkers Prev. 18 (2009) 121-131
30. Gershenson D.M. SEER data: perspective at 10,000 feet. Gynecol. Oncol. 110 (2008) 121-122
31. Harper S., Lynch J., Meersman S.C., Breen N., Davis W.W., and Reichman M.C. An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992-2004. Am. J. Epidemiol. 167 (2008) 889-899
32. Colon-Otero G., Smallridge R.C., Solberg Jr. L.A., Keith T.D., Woodward T.A., Willis F.B., et al. Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112 (2008) 447-454